We sent out a webinar link yesterday to those who contacted us. A link will be going out to all registered attendees at 9.45 - please email if you have not received it.

Really excited to be attending my first FTDUK conference. Attending conferences in person is so much better than online. It's also fantastic that Alzheimer's Society is sponsoring the ECR prizes.

Underway at FTD UK 2023 meeting with some excellent talks on synaptic biomarkers from @aitanasogorb Maura Malpetti and Mica Clarke

If you are attending the webinar please send in any questions via the chat or Twitter or email!

Nice to see over 100 people have made it in person despite the rail strikes today! Over 50 attendees on line so far. Next talk is Prof Jenna Gregory from the University of Aberdeen. #endftd

Lovely to see new collaborations happening over coffee at FTD UK!

After an excellent morning of clinical and basic science, now on to therapeutics with talks first from ARKUDA Therapeutics and then AviadoBio #endftd

FTDUK Thanks to everyone involved in organizing #FTD UK. Great talks, many of which highlighting synapses and glutamatergic neurons! Interestingly, our recent study on #brain #DNAmethylation (rdcu.be/dbAQ2) also implicates dysregulation glutamatergic synapses in #FLTD! 😊

Thanks to everyone who spoke and attended the meeting on Friday. Thanks to @aitanasogorb Mica Clarke and Lucy Russell who helped organize things UCL Queen Square Institute of Neurology. Next year is in Cambridge - please do email us with thoughts for talks and speakers via the website: ftduk.org

Read the latest FTDUK blog post all about this year’s FTD-UK conference (by Phoebe Foster ) via the link below! 😀 was such a great event, already looking forward to the next year! 🥼🧬 Read here: ftdtalk.org/2023/05/highli…

This year’s FTD UK meeting will be May 15th in Cambridge - registration is already open via the website ftduk.org. Programme to follow! Please join us. #endftd

Looking forward to this year’s FTD UK meeting on May 15th. Programme now available - speakers will include Tammaryn Lashley Dr. Steph Fowler Anna Sanchez Avila Alchemab Therapeutics and Orchard Therapeutics - U.S.. Please do enter our ECR prize as well. #endftd

Come and join us at FTD UK 15th May in Cambridge ftduk.org fantastic programme - be sure to apply for the ECR prize if eligible 🤩🤓👌🏻

Final programme now online for May 15th’s meeting - ftduk.org. From digital metrics (Rhian Convery) and novel pathology (Tammaryn Lashley) to TBK1 models, extracellular vesicles (Dr. Steph Fowler) and TDP-43 (Anna Sanchez Avila), with novel therapies (Orchard Therapeutics - U.S., Alchemab Therapeutics).

Make sure you come to FTDUK this year - it's on 15th May in Cambridge, and is entirely FREE to register! ftduk.org

FTDUK 11th annual meeting starts in an hour! IT set, Coffee set, Team ready - ⁦Jon Rohrer⁩ ⁦Bowles Lab⁩ ⁦Prof Jenna Gregory⁩ -

FTD UK annual meeting (number 11) today in Cambridge @MRC_LMB - amazing first clinical and cognitive session already done and now on molecular biology with Owen Peters from Cardiff UK Dementia Research Institute.

Great talk from Dr. Steph Fowler to finish an exciting morning!

Fab day at the FTDUK meeting filled with fantastic talks and lots of interesting discussions! 🧠🧫 a special shoutout to Rhian Convery for two fab talks & winning the ECR Clinical Science Prize ☺️ FTDtalk Cambridge FTD

We had an amazing time at the Frontotemporal Dementia UK (FTDUK) meeting in the LMB in Cambridge. Can’t wait to co-organise the meeting next year in Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿🌟🤩🌟🏴󠁧󠁢󠁳󠁣󠁴󠁿